Document is current
Any future updates will be listed below
-
Authors
Lewin, Jörn
Kottwitz, Denise
Aoyama, Johanna
deVos, Theo http://orcid.org/0000-0003-2085-2844
Garces, Jorge
Hasinger, Oliver
Kasielke, Stefanie
Knaust, Florian
Rathi, Preeti
Rausch, Sebastian
Weiss, Gunter
Zipprich, Alexander
Mena, Edward
Fong, Tse-Ling
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03804593 at ClinicalTrials.govDocuments that mention this clinical trial
Liquid biopsy in the clinical management of hepatocellular carcinoma
https://doi.org/10.1136/gutjnl-2019-320282
Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study
https://doi.org/10.1186/s12876-021-01714-8
-
Funding
Funding for this research was provided by:
Epigenomics AG
- License Information
-
More Information
Article History
Received: 24 September 2020
Accepted: 9 March 2021
First Online: 25 March 2021
Declarations
:
: Samples from University Halle-Wittenberg, were collected with consent under ethical approval No. 2012-5. The study collection protocol was approved by the Institutional Review Boards at the University of Southern California (USC) Keck Medical Center and the California Liver Research Institute. At both sites and patients provided written informed consent prior to study participation.
: Not applicable.
: Authors indicated by <sup>1,2</sup> are full time employees of Epigenomics AG, the sponsor of the study.
